| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |